Med-Chemist: daclatasvir

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label daclatasvir. Show all posts

Showing posts with label daclatasvir. Show all posts

Friday, April 15, 2016

FDA Approves Expanded Use of Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C

In continuation of my update on Daclatasvir Bristol-Myers Squibb Company (NYSE:BMY) announced today that Daklinza (daclatasvir,...

Tuesday, September 22, 2015

AWMSG recommends Daklinza (daclatasvir) for treatment of adult patients with chronic HCV infection

In continuation of my update on daclatasvir The All Wales Medicines Strategy Group (AWMSG) has recommended Daklinza ® (daclatasvi...

Wednesday, January 25, 2012

New Drug Combo for Hepatitis C Shows Promise...

A new cocktail of two investigational drugs appears to have successfully cleared the hepatitis C virus in people who don't respond to...

View web version

Contributors

Dr. Umesh..
https://www.med-chemist.com

Powered by Blogger.